AssayIndex
Homopeptide cross-section

Homopeptide by compound

Homopeptide records split by compound, with the index-wide comparison for the same compound beside each one. 36 compounds, 575 records. Cells below n=3 print their raw values instead of a median.

36 compounds575 records
CompoundClassReportsHomopeptide median %Index median %Δ (pp)SpecPass %
SemaglutideIncretin12199.2098.87+0.3397.0100
RetatrutideIncretin7298.5398.41+0.1296.5100
Melanotan IIMelanocortin-receptor3799.2699.24+0.0298.595
GHRP-6Growth-hormone3399.9399.65+0.2899.0100
TirzepatideIncretin2898.6798.44+0.2397.0100
TB-500Tissue-repair2699.3899.47-0.0998.5100
BPC-157Tissue-repair2599.3999.15+0.2498.0100
SemaxNeuroactive2399.6999.17+0.5298.5100
SS-31 (Elamipretide)Metabolic2299.6499.42+0.2298.595
N-Acetyl Semax AmideNeuroactive1899.2799.26+0.0098.5100
KPVTissue-repair1399.2899.21+0.0799.062
IpamorelinGrowth-hormone1299.5399.48+0.0599.0100
LL-37Tissue-repair1299.3098.61+0.6996.5100
PT-141 (Bremelanotide)Melanocortin-receptor1299.5299.31+0.2098.5100
GHRP-2Growth-hormone1199.5999.22+0.3799.0100
MK-677 (Ibutamoren mesylate)Non-peptide1199.8399.37+0.4698.5100
Humanin (HNG)Metabolic1199.7199.47+0.2497.5100
L-CarnosineShort1099.4799.07+0.4199.090
SurvodutideIncretin999.5798.69+0.8896.5100
SLU-PP-332Non-peptide899.5098.69+0.8298.0100
LiraglutideIncretin899.9399.02+0.9297.5100
LeuprolideHypothalamic899.5799.01+0.5698.5100
L-Glutathione (reduced)Short899.1999.00+0.1998.5100
CJC-1295 (no DAC)Growth-hormone7 n=799.3398.61+0.7298.0100
AfamelanotideMelanocortin-receptor6 n=699.1299.28-0.1698.0100
GHK-CuTissue-repair6 n=699.0098.54+0.4697.0100
HexarelinGrowth-hormone3 n=399.9398.72+1.2199.0100
ARA-290Tissue-repair3 n=399.7499.45+0.2998.0100
PEG-MGFGrowth-hormone3 n=398.4797.92+0.5592.0100
EpitalonShort2 n=2n<398.6399.0100
OxytocinHypothalamic2 n=2n<399.5798.5100
IGF-1 LR3Growth-hormone1 n=1n<397.7595.0100
GlucagonIncretin1 n=1n<398.7898.0100
DihexaNeuroactive1 n=1n<399.8498.5100
SelankNeuroactive1 n=1n<399.1399.0100
MOTS-cMetabolic1 n=1n<399.1898.0100
96.997.598.098.599.199.6100.2SemaglutideSemaglutide: Q1 98.94, median 99.20, Q3 99.61, n=121outlier 97.76n=121RetatrutideRetatrutide: Q1 98.15, median 98.53, Q3 98.89, n=72n=72Melanotan IIMelanotan II: Q1 99.01, median 99.26, Q3 99.73, n=37n=37GHRP-6GHRP-6: Q1 99.75, median 99.93, Q3 99.93, n=33outlier 99.25outlier 99.45n=33TirzepatideTirzepatide: Q1 98.32, median 98.67, Q3 98.99, n=28n=28TB-500TB-500: Q1 99.13, median 99.38, Q3 99.69, n=26n=26BPC-157BPC-157: Q1 99.26, median 99.39, Q3 99.71, n=25n=25SemaxSemax: Q1 99.44, median 99.69, Q3 99.93, n=23n=23SS-31 (Elamipretide)SS-31 (Elamipretide): Q1 99.24, median 99.64, Q3 99.93, n=22n=22N-Acetyl Semax AmideN-Acetyl Semax Amide: Q1 99.04, median 99.27, Q3 99.60, n=18n=18KPVKPV: Q1 98.92, median 99.28, Q3 99.59, n=13n=13IpamorelinIpamorelin: Q1 99.36, median 99.53, Q3 99.79, n=12n=12LL-37LL-37: Q1 99.05, median 99.30, Q3 99.58, n=12n=12PT-141 (Bremelanotide)PT-141 (Bremelanotide): Q1 99.35, median 99.52, Q3 99.83, n=12n=12 Purity (% area)
Figure. Distribution per compound where n ≥ 4. Rows are ordered by coverage, not by result.